Call(WhatsApp Us)
+8615360806100Email Us
cherry@laeyo.comSee the factory by live video walkthrough
Book an on-site factory visit in GuangzhouSwitching manufacturers mid-flight is rarely just a supplier swap. For a Saudi skincare brand, the formula may survive the move intact — but the approved artwork usually does not. Artwork is not a design…
Switching manufacturers mid-flight is rarely just a supplier swap. For a Saudi skincare brand, the formula may survive the move intact — but the approved artwork usually does not. Artwork is not a design file; it is a regulated document that ties a specific product to a specific manufacturing site, a specific formula version, a specific importer/notifier, and a specific notification record. This guide walks through what actually changes, which decisions must be made before you send a single file to print, and which evidence to collect so your relaunch does not stall at customs or at the label desk.
In the Saudi framework — the SFDA cosmetics framework layered with GSO safety and claims standards — the label is one of the primary control points. It is read alongside the notification file, not in isolation. When the manufacturing site changes, several artwork fields stop being true at the same moment.
Practical rule: treat artwork as a controlled document with a version number, a change log, and a named approver. If you cannot state which artwork version was approved, for which site, and against which formula, you are not ready to print.
Everything downstream — timeline, testing, artwork scope — depends on this classification. Get it wrong and you either over-test or under-document.
| Scenario | What it means | Artwork impact | Minimum extra work |
|---|---|---|---|
| A — Site transfer, same formula, same ingredient suppliers | Lowest risk. Same recipe, same raw materials, different building. | Manufacturer block, facility references, batch coding format, possibly country of origin. | Site-level verification: GMP certificate, equipment/process comparison, stability and micro at the new site, label adhesion on the production pack. |
| B — Same formula, new ingredient suppliers | Identical INCI names, different source. Activity level, salts, solvents, particle size, impurities, colour, odour, and preservative interactions can all shift. | Usually no change to INCI text, but warnings, allergen declarations, and claims support may change. | Supplier-change control: COA comparison, small trial, key stability, viscosity/pH/appearance, sensory evaluation, preservative and efficacy checks as needed, cost and supply review. |
| C — Reformulation or new claims | Highest risk. New INCI list, new efficacy evidence, potentially a new product identity. | Full artwork rebuild. New INCI, new claims, new substantiation, new notification data. | Full development and safety file: stability, micro, compatibility, claim testing, updated fragrance documentation. |
If you are unsure, assume Scenario B until the COA comparison proves otherwise. “Same INCI” is not evidence of sameness.
Use this as a redline worksheet. Every row you tick must be backed by a document — not by a verbal confirmation.
| Artwork element | Changes on manufacturer switch? | Evidence to request | Owner |
|---|---|---|---|
| Manufacturer name and address | Almost always | Current facility license / GMP certificate naming the site | Manufacturer |
| INCI declaration | Only if formula or supplier grades change | Signed formula + ingredient-to-INCI mapping + COAs | Manufacturer |
| Importer / notifier block | Only if the responsible entity changes | Written confirmation of notifier identity and role | Buyer / Importer |
| Notification reference (if printed) | Yes, if the record is updated | Updated notification record from the SFDA electronic system | Importer / Notifier |
| Batch and expiry coding | Often — new site, new coding hardware | Printed-sample photo showing actual batch and expiry format | Manufacturer |
| Warnings and allergen statements | Possibly, if fragrance or preservative system changes | IFRA certificate written against the actual product use category, plus allergen declaration | Fragrance house / Manufacturer |
| Claims and directions for use | Possibly — must remain supportable | Claim substantiation file mapped claim-by-claim to test data | Buyer / Manufacturer |
| Net content and units | Only if fill weight or format changes | Fill-weight control spec and check-weigher records | Manufacturer |
| Barcode / GS1 data | No, unless the GTIN changes with the brand owner | GS1 registration confirmation and barcode verification report | Buyer |
| Label substrate and adhesive | Yes, in practice — new bottle supplier, new press | Label adhesion and artwork compatibility report on production containers | Packaging supplier / Manufacturer |
Most delays at this stage are not technical failures — they are ownership failures. Agree the split in writing before the artwork redline begins.
| Workstream | Owner | Deliverable |
|---|---|---|
| Formula, specification, INCI mapping | Manufacturer | Signed formula and spec sheet |
| Safety and technical documents | Manufacturer + fragrance house | COA, SDS, IFRA certificate matched to real use category |
| Stability, microbiology, packaging compatibility | Manufacturer / contracted lab | Protocols plus signed reports by batch |
| Product notification, import permit, local barcodes | Saudi importer / notifier | Notification record and import approval |
| Final Arabic and English label approval | Buyer / importer | Signed label approval sheet |
| Advertising and claim compliance | Buyer with regulatory review | Approved claim list with substantiation |
Fast path is only available in Scenario A, with an unchanged formula, unchanged fragrance, unchanged packaging supplier, and a notifier who confirms in writing that no file update is required. What can compress: design rounds, translation turnaround, and printing lead time. What cannot compress: stability and micro at the new site, and the pilot run.
Standard path applies to Scenario B and C, or to any case where the notifier has not yet confirmed the file status. Budget for supplier-change evaluation, a fresh stability window, and a full label review cycle.
Confirm the change scenario: site transfer, supplier change, or reformulation.
Share the current approved artwork PDF with its version number and approval date.
Provide the new site's GMP certificate and facility license with expiry date.
Provide the signed formula and an ingredient-to-INCI mapping for the current version.
Attach COAs for all raw materials from the intended production lots.
Confirm whether any raw material supplier or grade changed versus the previous site.
Provide the IFRA certificate written against our actual product use category.
Attach the full allergen declaration for the fragrance as used.
Confirm stability protocol, timepoints, and whether new-site data already exists.
Confirm microbiological and preservative efficacy testing status at the new site.
Test label adhesion on the production container and share photographs.
Test pump dose, leak performance, and sealing integrity on the pilot batch.
Provide the viscosity and pH specification with measured pilot values.
List every artwork field that must change, with the document that justifies it.
Review all claims against the approved claim list and flag anything unsupported.
Confirm the batch and expiry coding format with a printed sample image.
Verify barcode and GTIN data with a barcode verification report.
Send a pre-press proof for written approval before printing.
Run the pilot and send first-article samples plus inspection photographs.
Confirm in writing who is the Saudi notifier and whether the file needs updating.
List the documents the notifier requires from the manufacturing site.
Approve final Arabic and English label text before mass production.
Hold commercial release until notification and import documentation are confirmed.
Archive the released artwork with its full evidence pack.
Rarely in full. Manufacturer name and address, facility references, and batch coding usually change. INCI text stays only if the formula and all raw material grades are genuinely identical — which must be proven by a COA comparison, not assumed from matching INCI names.
The Saudi importer or notifier is the responsible entity and owns the notification, import permit, local barcode data, and final Arabic/English label approval. The manufacturer supplies the underlying technical documents: formula, COA/SDS, GMP evidence, labels, samples, and stability or sealing data. Agree this split in writing at kickoff.
Yes, in most cases. Stability and preservative efficacy results are site- and process-specific. Even with an identical formula, equipment, water systems, filling conditions, and hold times differ and can change the outcome.
It depends almost entirely on the scenario and on how quickly the notifier responds. A clean site transfer with existing documentation and a confirmed no-update file can move in weeks. A supplier change or reformulation adds trial work, a stability window, and a full label review cycle. Plan artwork approval after the pilot, never before.
Print only fields that are already proven. Anything dependent on pending stability, fragrance documentation, or notification status should be held. Reprinting cartons costs far more than a two-week wait.
Send us the current approved artwork, the target market, your SKU list and formats, your positioning, your packaging direction, and your launch window. We will map the change scenario, list which artwork fields need new evidence, and return a document request list you can forward to your notifier the same day.
Informational only, not legal advice. Regulatory requirements and notification procedures should be confirmed with your Saudi notifier and qualified regulatory counsel.